Prognostic value of hematologic parameters in advanced non-small cell lung cancer patients receiving anti-PD-1 inhibitors

BACKGROUND: The association between hematologic parameters and anti-programmed death-1 (PD-1) inhibitors was generally examined without considering therapy lines and medicine types. The study was aimed to identify potential hematologic biomarkers associated with clinical outcome in patients with non...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xinmin, Wu, Xianghua, Yu, Hui, Wang, Huijie, Sun, Si, Hu, Zhihuang, Liu, Cuicui, Zhang, Junli, Shao, Yang, Wang, Jialei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631308/
https://www.ncbi.nlm.nih.gov/pubmed/36341410
http://dx.doi.org/10.3389/fimmu.2022.1003581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631308/
https://www.ncbi.nlm.nih.gov/pubmed/36341410
http://dx.doi.org/10.3389/fimmu.2022.1003581

Ejemplares similares